Abstract: Background: One of the most important goals of treatment in inflammatory bowel disease (IBD) is the overall improvement of patients Quality of Life (QOL), both Crohn's and ulcerative colitis needs lifelong drug treatment in order to maintain remission, This study has investigated the variables which can be attributed to Health related Quality of life (HRQOL) in patients with IBD. Medication non-adherence is common in inflammatory bowel diseases (IBD). The short-term consequences of non-adherence include increased disease relapse but the long-term impact upon patients in terms of daily functional impairment are less well characterized. Identifying negative....
Key Word: IBD, HRQOL, non-adherence, drug compliance, Complications, T.Mesocal, Multivitamin, Sulphasalazine
[1]. Acharya, J. P., & Acharya, I. (2014). Socio demographic factors influencing compliance of medication in an urban OPD setting. Journal of the Scientific Society, 41(2), 101. https://doi.org/10.4103/0974-5009.132842
[2]. Alowais, F. A., Alferayan, Y. A., & Aljehani, R. M. (2016). Inflammatory Bowel Disease and Quality of Life in King Abdul-Aziz Medical City. Open Journal of Gastroenterology, 06(01), 11–16. https://doi.org/10.4236/ojgas.2016.61003
[3]. Bähler, C., Schoepfer, A., Vavricka, S., Brüngger, B., & Reich, O. (2017). Chronic comorbidities associated with inflammatory bowel disease: Prevalence and impact on healthcare costs in Switzerland. European Journal of Gastroenterology & Hepatology, 29(8), 916–925. https://doi.org/10.1097/MEG.0000000000000891
[4]. Bernstein, C., Kraut, A., Blanchard, J., Rawsthorne, P., Yu, N., & Walld, R. (2017). The Relationship between Inflammatory Bowel Disease and Socioeconomic Variables. American Journal of Gastroenterology, 96(7), 2117–2125. https://doi.org/10.1111/j.1572-0241.2001.03946.x
[5]. Betteridge, J. D., Armbruster, S. P., Maydonovitch, C., & Veerappan, G. R. (2013). Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population. Inflammatory Bowel Diseases, 19(7), 1421–1427. https://doi.org/10.1097/MIB.0b013e318281334d